Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Burden of Colorectal Cancer in Yazd Province in 2016



Jafarabadi Z1 ; Abolhasani F2 ; Lotfi MH3 ; Fallahzadeh H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  2. 2. National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Social Determinants of Health Research Center, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Source: Iranian Journal of Epidemiology Published:2022

Abstract

Background and Objectives: Colorectal cancer is the second and fourth most common cancer in Iranian women and men, respectively. This cancer ranks fourth and fifth in men and women, respectively, among Yazd population. This study aimed to estimate the burden of colorectal cancer in Yazd province in 2016. Methods: This descriptive cross-sectional study was performed on the population of Yazd province in 2016. CanMod software was used to calculate the burden of colorectal cancer. The required information included the population of Yazd province, the incidence of colorectal cancer, the death rate due to colorectal cancer, the death rate due to all causes and the survival rate of patients; The Cancer Registration System, the Provincial Death Registration System and the opinions of provincial experts were collected and included, respectively. Results: The total burden of colorectal cancer in Yazd province was 632 years (382 years in men and 250 years in women); The YLL and YLD of colorectal cancer in both genders were 478 years and 154 years, respectively. The burden of colorectal cancer in men was 65 years and in women 45 years (per 100,000 population). The peak age of disease burden was estimated in the age group over 60. Conclusion: Due to the high incidence and treatment in the early stages of the disease, screening and diagnosis in the early stages can be one of the health priorities of the province. However, the final judgment is made when the burden of other diseases and injuries is calculated in the province. © 2022 The Authors.
Related Docs
View other Related Docs
1. Estimating the Burden of Breast Cancer in Iranian Women in 2009, Iranian Journal of Epidemiology (2015)
2. Toxic Mechanisms of Cadmium and Exposure As a Risk Factor for Oral and Gastrointestinal Carcinomas, Human and Experimental Toxicology (2023)
3. Resource Use and Costs Associated to the Initial Phase of Treatment for Patients With Colorectal Cancer Receiving Post-Surgery Chemotherapy: A Cost Analysis From a Healthcare Perspective, Iranian Journal of Public Health (2021)
4. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
5. The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the Globocan 2012 to 2018 Estimates, Value in Health Regional Issues (2022)
6. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
7. Prognostic Factors of Disease Recurrence and Overall Survival Following Curative Resection of Colon Cancer: A 10-Year Cohort From a Referral Center, Medical Journal of the Islamic Republic of Iran (2022)
8. Economic Burden of Colorectal Cancer in Iran in 2012, Medical Journal of the Islamic Republic of Iran (2017)
Experts (# of related papers)
View all Related Experts
Reza Malekzadeh (11)
Kazem Zendehdel (8)
Other Related Docs
9. Diagnostic Value of Peripheral Blood Inflammatory Indices for Clinicopathological Profile of Colorectal Cancer: A Retrospective Observational Study, BMC Gastroenterology (2025)
10. Heterogeneous Expression of Long Noncoding Rna Rp11-109D20.2: Insights Into Regulatory Gene Expression Roles in Colon Cancer, Iranian Journal of Basic Medical Sciences (2025)
11. Guanylate Cyclase-C Signaling Axis As a Theragnostic Target in Colorectal Cancer: A Systematic Review of Literature, Frontiers in Oncology (2023)
12. Disability-Adjusted Life Years (Daly) for Cancers in Iran, 1990 to 2016: Review of Findings From the Global Burden of Disease Study, Iranian Journal of Public Health (2021)
13. The Therapeutic Effect of Exosomes From Mesenchymal Stem Cells on Colorectal Cancer: Toward Cell-Free Therapy, Pathology Research and Practice (2022)
14. Association Between Dietary Fat Intake and Colorectal Cancer: A Multicenter Case-Control Study in Iran, Frontiers in Nutrition (2022)
15. Analysis of Sdc2 Gene Promoter Methylation in Whole Blood for Noninvasive Early Detection of Colorectal Cancer, Journal of Cancer Research and Therapeutics (2022)
16. The Critical Role of Circular Rnas in Drug Resistance in Gastrointestinal Cancers, Medical Oncology (2023)
17. Assessment of Salivary Mirna, Clinical, and Demographic Characterization in Colorectal Cancer Diagnosis, Translational Oncology (2024)
18. The Potential of Pik3ca, Kras, Braf, and Apc Hotspot Mutations As a Non-Invasive Detection Method for Colorectal Cancer, Molecular and Cellular Probes (2022)
19. Short-Course Versus Long-Course Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: Preliminary Results of a Randomized Controlled Trial, Radiation Oncology Journal (2020)
20. Cost–Benefit Analysis of Human Papillomavirus Vaccine in Iran, Journal of Prevention (2022)
21. The Association Between Planetary Health Diet Index and the Risk of Colorectal Cancer: A Case-Control Study, Scientific Reports (2024)
22. Association Between Dietary Intake of Fatty Acids and Colorectal Cancer, a Case-Control Study, Frontiers in Nutrition (2022)
23. The Importance of Evaluating Serum Levels of Tumor Markers M2-Pk and Inhibin a in Patients Undergoing Colonoscopy, Technology in Cancer Research and Treatment (2023)
24. World Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data Synthesis, PLoS Medicine (2015)
25. Economic Burden of Prostate Cancer in Iran: Measuring Costs and Quality of Life, Middle East Journal of Cancer (2019)
26. Economic Burden of Gynecological Cancers in Iran, Value in Health Regional Issues (2022)
27. Direct and Indirect Medical Costs of Bladder Cancer in Iran, Cost Effectiveness and Resource Allocation (2023)
28. Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study, Archives of Iranian Medicine (2023)
29. Burden of Oral Diseases in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
30. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
31. Mortality Rates and Years of Life Lost Due to Cancer in Iran: Analysis of Data From the National Death Registration System, 2016, International Journal of Cancer Management (2022)
32. A Review of Incidence and Mortality of Colorectal, Lung, Liver, Thyroid, and Bladder Cancers in Iran and Compared to Other Countries, Wspolczesna Onkologia (2019)
33. Applications of Artificial Intelligence in Screening, Diagnosis, Treatment, and Prediction of Prognosis of Colorectal Cancer; [و پیش بینی پیش آگهی سرطان کولورکتال کاربرد هوش مصنوعی در غربالگری، تشخیص، درمان،], Govaresh (2024)
34. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
35. Trends in Health Burden of Ambient Particulate Matter Pollution in Iran, 1990–2010: Findings From the Global Burden of Disease Study 2010, Environmental Science and Pollution Research (2015)
36. Lncrna Malat1 As Diagnostic and Prognostic Biomarker in Colorectal Cancers: A Systematic Review and Meta-Analysis, PLoS ONE (2024)
37. The Association Between Vitamin C and Breast Cancer, Prostate Cancer and Colorectal Cancer: A Systematic Review and Meta-Analysis, Clinical Nutrition ESPEN (2025)
38. The Global Burden of Viral Hepatitis From 1990 to 2013: Findings From the Global Burden of Disease Study 2013, The Lancet (2016)
39. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)
40. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration, JAMA Oncology (2017)
41. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention, Cancers (2024)
42. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale), 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
43. Naringenin: A Potential Flavonoid Phytochemical for Cancer Therapy, Life Sciences (2022)
44. Role of Dietary Intake of Specific Polyunsaturated Fatty Acids (Pufas) on Colorectal Cancer Risk in Iran, Lipids (2024)
45. Short-Course Versus Long-Course Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: Long-Term Results of a Randomized Controlled Trial, International Journal of Colorectal Disease (2025)
46. Determinants of Early-Onset Colorectal Cancer: A Multicenter Case-Control Study in Iran, European Journal of Cancer Prevention (2024)
47. Patterns of Better Breast Cancer Care in Countries With Higher Human Development Index and Healthcare Expenditure: Insights From Globocan 2020, Frontiers in Public Health (2023)
48. Cancer in Iran 2008 to 2025: Recent Incidence Trends and Short-Term Predictions of the Future Burden, International Journal of Cancer (2021)
49. Dietary Diversity Score (Dds) and Odds of Colorectal Cancer and Adenoma: A Case-Control Study, Journal of Nutritional Science (2022)
50. Association Between Prediagnostic Risk Factors and Survival After Colorectal Cancer Diagnosis in Golesten Cohort Study, Scientific Reports (2025)